MetLife, Inc.
MET
$97.66
$0.190.20%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 19.29B | 18.36B | 23.49B | 17.32B | 17.57B |
| Total Other Revenue | -132.00M | 713.00M | 328.00M | 43.00M | -228.00M |
| Total Revenue | 19.15B | 19.07B | 23.81B | 17.36B | 17.34B |
| Cost of Revenue | 14.55B | 13.65B | 19.28B | 12.91B | 13.32B |
| Gross Profit | 4.61B | 5.43B | 4.53B | 4.46B | 4.02B |
| SG&A Expenses | -- | -- | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 3.55B | 3.53B | 3.42B | 3.24B | 3.05B |
| Total Operating Expenses | 18.10B | 17.18B | 22.70B | 16.14B | 16.37B |
| Operating Income | 1.06B | 1.89B | 1.11B | 1.22B | 972.00M |
| Income Before Tax | 1.04B | 1.51B | 1.12B | 1.21B | 980.00M |
| Income Tax Expenses | 256.00M | 345.00M | 301.00M | 308.00M | 245.00M |
| Earnings from Continuing Operations | 779.00M | 1.16B | 816.00M | 902.00M | 735.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -43.00M | 23.00M | -7.00M | -6.00M | -6.00M |
| Net Income | 736.00M | 1.19B | 809.00M | 896.00M | 729.00M |
| EBIT | 1.06B | 1.89B | 1.11B | 1.22B | 972.00M |
| EBITDA | 1.10B | 1.92B | 1.78B | 1.25B | 1.00B |
| EPS Basic | 1.10 | 1.75 | 1.18 | 1.23 | 1.04 |
| Normalized Basic EPS | 0.94 | 1.48 | 1.05 | 1.13 | 0.90 |
| EPS Diluted | 1.09 | 1.74 | 1.17 | 1.22 | 1.03 |
| Normalized Diluted EPS | 0.93 | 1.47 | 1.04 | 1.12 | 0.90 |
| Average Basic Shares Outstanding | 642.60M | 652.00M | 658.10M | 664.70M | 670.80M |
| Average Diluted Shares Outstanding | 646.90M | 655.70M | 662.20M | 669.10M | 675.00M |
| Dividend Per Share | 0.59 | 0.57 | 0.57 | 0.57 | 0.57 |
| Payout Ratio | 56.25% | 35.19% | 50.19% | 49.55% | 56.65% |